Cotransplantation of Mesenchymal Stem Cells and Immature Dendritic Cells Potentiates the Blood Glucose Control of Islet Allografts

Figure 3

Flow cytometry analysis of imDC surface markers. On day 7 after stimulation, the cells were stained with CD11c, MHC-II, CD86, and CD80 antibodies and identified with flow cytometry: 89.9% of the cells were CD11c-positive (a) and 36.61% were MHC-II positive (b), while only 5.03% of cells were CD80-positive (c) and 1.5% cells were CD86-positive (d), which are consistent with the surface characteristics of imDCs.

(a)

(b)

(c)

(d)